ArticleGlobal health action
So let me find my way, whatever it will cost me, rather than leaving myself in darkness: experiences of glaucoma in Nigeria.
Article in Global health action. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Factors that influence eye care utilization in Nigeria: a systematic review.BMC public health · 2026Pooled it
- The adaptation and psychometric validation of a stigma measure for adults diagnosed with severe vision impairment in rural Mozambique.BMC psychology · 2026Article
- Awareness and care journey of Glaucoma patients attending three referral hospitals in South-East Nigeria: Implications for public health intervention.International ophthalmology · 2026Article
- Article
- The patient-based socioeconomic burden of glaucoma care in nigeria: a scoping review.International ophthalmology · 2025Article
- Determinants of blindness from glaucoma among patients receiving treatment: a retrospective cohort study in Enugu, Nigeria.BMC ophthalmology · 2025Article
- Lived experiences and coping strategies of people living with Glaucoma in Nigeria: A qualitative study.PloS one · 2025Article
- Factors limiting glaucoma care among glaucoma patients in Nigeria: A scoping review.PLOS global public health · 2024Article
- Minimum requirements for a glaucoma programme.Community eye health · 2021Article
- West Indies Glaucoma Laser Study (WIGLS) 3. Anterior Chamber Inflammation Following Selective Laser Trabeculoplasty in Afro-Caribbeans with Open-angle Glaucoma.Journal of glaucoma · 2019Article
- Validity and Reliability of the Glaucoma Knowledge Level Questionnaire.Turkish journal of ophthalmology · 2018Article
- LONG TERM OUTCOMES OF AUGMENTED TRABECULECTOMY WITH 5-FLUOROURACIL IN NIGERIA.Journal of the West African College of SurgeonsArticle
- A scoping review of patients' barriers to eye care for glaucoma and keratitis.Survey of ophthalmologyArticle
- Eye Care Practices, Knowledge, and Attitude of Glaucoma Patients at Community Eye Outreach Screening in Nigeria.Journal of the West African College of SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlindness from glaucoma is associated with socio-economic deprivation, presumed to reflect poor access to care and poor adherence to treatment.
objectivesTo determine why people with glaucoma are presenting late for treatment and to understand access to glaucoma care. Additionally, we sought to identify what patients and the community know, do and think about the condition and why the poor are the most affected with glaucoma blindness.
designStudy participants were from four communities and two hospitals in Abuja-FCT and Kaduna State, Nigeria. A total of 120 participants were involved, including 8 focus group discussions, 7 in-depth interviews with blind/visually impaired glaucoma patients, 5 rapid direct observation visits with these patients and 13 exit interviews of glaucoma patients in the hospital. The data were analysed using content analysis, interpreting participant experiences in terms of three key steps conceptualised as important in the care pathway: what it takes to know glaucoma, to reach a diagnosis and to access continued care.
resultsThis article presents multiple narratives of accessing and maintaining glaucoma care and how people manage and cope with the disease. People may be presenting late due to structural barriers, which include lack of knowledge and awareness about glaucoma and not finding an appropriately equipped health care facility. What keeps glaucoma patients within the care pathway are a good hospital experience; a support structure involving family, counselling and shared patients' experiences; and an informed choice of treatment, as well as agency. The high cost of purchasing care is a major factor for patients dropping out of treatment.
conclusionThe findings suggest the need to address economic and social structural drivers as glaucoma presents another case study to demonstrate that poverty is a strong driver for blindness. There is also a need for clear glaucoma care pathways with early case finding in the community, two-way referral/feedback systems, well-equipped glaucoma care hospitals and better eye health care financing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.